Canada’s legal cannabis industry has been struggling with mislabeled products since adult-use sales were legalized in 2018, but a new study confirms “discrepancies” in the information displayed on goods containing marijuana oil.
In what is believed to be the first Canadian study about the labeling of regulated products containing cannabis oil, authors James MacKillop, a professor of psychiatry and behavioral neurosciences at McMaster University, and Amanda Doggett, a postdoctoral fellow at the school in Hamilton, Ontario, found “discrepancies at multiple levels,” according to online outlet Medscape Medical News.
ADVERTISEMENT
A third of the cannabis oil products secured by MacKillop and Doggett for the study “differed from their online tetrahydrocannabinol (THC) and cannabidiol (CBD) descriptions, and 16.7% had conflicting information on the label,” Medscape reported,
Read full article on Marijuana Business Daily
